Published in Front Cell Neurosci on May 28, 2015
Potential application of lithium in Parkinson's and other neurodegenerative diseases. Front Neurosci (2015) 0.81
Feature Selection Has a Large Impact on One-Class Classification Accuracy for MicroRNAs in Plants. Adv Bioinformatics (2016) 0.80
Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement. BMC Neurosci (2015) 0.79
The impact of feature selection on one and two-class classification performance for plant microRNAs. PeerJ (2016) 0.77
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease. PLoS Genet (2017) 0.75
MicroRNA-34a promoting apoptosis of human lens epithelial cells through down-regulation of B-cell lymphoma-2 and silent information regulator. Int J Ophthalmol (2016) 0.75
Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis. Sci Rep (2017) 0.75
Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.75
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62
The role of site accessibility in microRNA target recognition. Nat Genet (2007) 18.52
A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell (2006) 14.70
Ensembl 2013. Nucleic Acids Res (2012) 11.70
Evolution, biogenesis, expression, and target predictions of a substantially expanded set of Drosophila microRNAs. Genome Res (2007) 9.61
miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res (2010) 5.72
Experimental strategies for microRNA target identification. Nucleic Acids Res (2011) 3.00
Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proc Natl Acad Sci U S A (2009) 2.54
MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet (2011) 1.92
Reactome knowledgebase of human biological pathways and processes. Methods Mol Biol (2011) 1.91
The role of oxidative stress in Parkinson's disease. J Parkinsons Dis (2013) 1.86
Regulation of Nrf2-an update. Free Radic Biol Med (2013) 1.81
GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther (2013) 1.80
Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology (2008) 1.79
miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull (2009) 1.66
Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal (2013) 1.65
MicroRNAs and their roles in aging. J Cell Sci (2012) 1.60
Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) (2001) 1.60
miR-34: from bench to bedside. Oncotarget (2014) 1.59
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev (2013) 1.52
Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD. Neurology (2015) 1.47
Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol (2013) 1.46
Classic and new animal models of Parkinson's disease. J Biomed Biotechnol (2012) 1.45
Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology (2002) 1.34
The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid Redox Signal (2009) 1.31
HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. J Biol Chem (2011) 1.28
Environmental toxins and Parkinson's disease. Annu Rev Pharmacol Toxicol (2013) 1.21
Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Prog Neurobiol (2013) 1.20
The emerging roles of microRNAs in CNS injuries. Nat Rev Neurol (2013) 1.18
The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease. Gene (2013) 1.18
Paraquat and Parkinson's disease. Cell Death Differ (2010) 1.17
Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases--a mechanistic approach. Toxicol Lett (2014) 1.14
miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J Am Soc Nephrol (2011) 1.14
Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs (2013) 1.11
Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J Biosci (2006) 1.06
Neural and immune mechanisms in the pathogenesis of Parkinson's disease. J Neuroimmune Pharmacol (2013) 1.02
Intracellular pathways underlying the effects of lithium. Behav Pharmacol (2010) 1.02
MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int J Neuropsychopharmacol (2009) 0.99
Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. Mol Psychiatry (2015) 0.99
Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci (2014) 0.98
The role of microRNAs in biological processes. Methods Mol Biol (2014) 0.97
Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim Biophys Acta (2013) 0.96
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
MicroRNAs: Small molecules with big roles in neurodevelopment and diseases. Exp Neurol (2014) 0.94
SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration. Oxid Med Cell Longev (2013) 0.93
Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation. Biol Mood Anxiety Disord (2012) 0.93
Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res (2013) 0.93
Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions. Am J Transl Res (2013) 0.92
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy. Front Cell Neurosci (2014) 0.92
New insights into antioxidant strategies against paraquat toxicity. Free Radic Res (2014) 0.92
Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication. Neurobiol Dis (2004) 0.91
Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. J Parkinsons Dis (2013) 0.91
Paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells: involvement of p53 and mitochondria. J Toxicol Environ Health A (2008) 0.90
The panorama of miRNA-mediated mechanisms in mammalian cells. Cell Mol Life Sci (2014) 0.90
The endotoxin-induced neuroinflammation model of Parkinson's disease. Parkinsons Dis (2011) 0.89
The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress. Int J Neuropsychopharmacol (2014) 0.88
Dietary regulation of Keap1/Nrf2/ARE pathway: focus on plant-derived compounds and trace minerals. Nutrients (2014) 0.87
Differential Effects of Methyl-4-Phenylpyridinium Ion, Rotenone, and Paraquat on Differentiated SH-SY5Y Cells. J Toxicol (2013) 0.86
Long-term exposure to low lithium concentrations stimulates proliferation, modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells. Neurochem Res (2008) 0.85
Hydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity. Toxicol Lett (2014) 0.84
The role of pesticide exposure in the genesis of Parkinson's disease: epidemiological studies and experimental data. Toxicology (2012) 0.83
Paraquat induces cyclooxygenase-2 (COX-2) implicated toxicity in human neuroblastoma SH-SY5Y cells. Toxicol Lett (2010) 0.82
Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons. Bipolar Disord (2014) 0.80
Thioredoxin system regulation in the central nervous system: experimental models and clinical evidence. Oxid Med Cell Longev (2014) 0.78
Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.78
Molecular regulation of synaptogenesis during associative learning and memory. Brain Res (2014) 0.77
The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice. Neurosci Lett (2011) 0.77
Interpreting magnetic resonance imaging findings in bipolar disorder. CNS Neurosci Ther (2012) 0.77
The toxic effect of lithium ion on neurons (PC12 cells) and Aβ42 molecules. Biol Trace Elem Res (2014) 0.76
Computational methods for ab initio detection of microRNAs. Front Genet (2012) 0.86